GENEVA, Sept. 7 -- THINKINGBIOMED TECHNOLOGY (BEIJING) CO.LTD. filed a patent application (CN2025/079913) for “DLL3-TARGETING ANTIBODY, CHIMERIC ANTIGEN RECEPTOR, AND USE THEREOF”. With publication no. WO/2026/178861, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 16/28
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....